Midatech Completes Acquisition of Zuplenz®
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Midatech Pharma (MTP) Announces Completion of Zuplenz Acquisition
December 30, 2015 7:22 AM ESTMidatech Pharma (Nasdaq: MTP) announces the successful completion of its previously announced acquisition of Zuplenz (ondansetron), a marketed oncology product from Galena Biopharma, Inc. (NASDAQ: GALE). Zuplenz® is marketed in the US for the prevention of chemotherapy-induced nausea and vomiting (CINV),... More
